Heart diseases
Conditions
Interventions
SMART group:SMART model management
usual care clinic group:No intervention, patients will be managed in the usual care clinics
anticoagulation clinic group:No intervention, patients will be managed in the anticoagulation clinics
Sponsors
The Second Xiangya Hospital of Central South University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who will continue to take warfarin in the next 12 months; 2. Patients who followed the protocol and randomization; 3. Patients who signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Subjects of pregnancy or pregnancy plan in the next 18 months; 2. Those who had been treated for bleeding adverse events in the past 6 months; 3. Those who can't go to the hospital within 6 hours; 4. Patients with advanced renal failure (hemodialysis or glomerular clearance rate < 10ml / min) 5. Patients with senile dementia or schizophrenia; 6. Patients receiving anti-cancer treatment; 7. Patients with congestive heart failure who need medical treatment; 8. Patients with history of bleeding such as gastric ulcer; 9. Patients taking aspirin and other antiplatelet drugs at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of time in therapeutic range; | — |
Secondary
| Measure | Time frame |
|---|---|
| the numbers of INR results 5.0;serious adverse clinical events;patients’ quality of life; | — |
Countries
China
Contacts
Public ContactShenglan Tan
The Second Xiangya Hospital of Central South University
Outcome results
None listed